High Blood Pressure News and Research

Latest High Blood Pressure News and Research

Researchers identify new genetic regions associated with heart attacks

In the largest genetic study of Coronary Artery Disease (CAD) to date, researchers from the CARDIoGRAMplusC4D Consortium report the identification of 15 genetic regions newly associated with the disease, bringing to 46 the number of regions associated with CAD risk.

3 Dec 2012

Scientists identify 15 new genetic regions associated with coronary artery disease

Fifteen new genetic regions associated with coronary artery disease have been identified by a large, international consortium of scientists - including researchers at the Stanford University School of Medicine - taking a significant step forward in understanding the root causes of this deadly disease. The new research brings the total number of validated genetic links with heart disease discovered through genome-wide association studies to 46.

3 Dec 2012

Men should see a doctor and be proactive about their health, say UAB experts

Experts at the University of Alabama at Birmingham (UAB) say a man's tendency to wait until the onset of sickness to see his doctor is a major detriment to health because key screenings are missed.

1 Dec 2012

New Weill Cornell campaign to improve hypertension prevention, detection and control

The Weill Cornell Physician Organization at Weill Cornell Medical College has joined more than 120 medical groups and health systems nationwide to launch the new health campaign Measure Up, Pressure Down aimed to improve high blood pressure prevention, detection and control.

1 Dec 2012

New national healthcare campaign aims at controlling high blood pressure

A majority of patients can't recall whether their physician mentioned their blood pressure numbers and among patients with high blood pressure, only 56 percent say they talked with their doctor about ways to reduce their high blood pressure, according to a new survey released today by the American Medical Group Foundation, the nonprofit education and research arm of the American Medical Group Association.

1 Dec 2012

Roundup: Conn. health care programs face $70M cut; Miss. abortion clinic again asks judge to block law that could force it to close

Connecticut's social services safety net and its public colleges and universities took the brunt Wednesday of Gov. Dannel P. Malloy's first effort to whittle down a $363 million state budget deficit.

30 Nov 2012

African Americans experience faster progression of CKD during later stages

Among individuals with chronic kidney disease (CKD), African Americans experience faster progression of the disease during later stages compared with other races, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

30 Nov 2012

AstraZeneca receives FDA approval for Cometriq to treat medullary thyroid cancer

The U.S. Food and Drug Administration today approved Cometriq (cabozantinib) to treat medullary thyroid cancer that has spread to other parts of the body (metastasized).

29 Nov 2012

University of Cincinnati to lead Belatacept Early Steroid withdrawal Trial

The University of Cincinnati will lead a $5.2 million national trial studying removal of both corticosteroids and common immunosuppression treatments from the post-transplant drug regimen for kidney transplant patients.

29 Nov 2012

$ACE-inhibitors, angiotensin receptor blockers can treat heart failure with preserved ejection fraction$

ACE-inhibitors, angiotensin receptor blockers can treat heart failure with preserved ejection fraction

A novel study from Karolinska Institutet in Sweden suggests that commonly used drugs to treat heart failure and high blood pressure may have a wider range of application than earlier known, and also can be used against so called HFPEF - a type of heart failure that until now has been impossible to treat.

29 Nov 2012

Overexpressed enzyme contributes to development of preeclampsia

Preeclampsia is a serious complication of pregnancy and the major cause of death for both mother and child in Europe and the U.S. It affects about one in 20 pregnancies. The main symptoms are high blood pressure and protein in the urine.

26 Nov 2012

Bowel cancer and GIST patients could benefit from novel oral drug

Two phase 3 trials, published in The Lancet, have shown that a novel oral drug called regorafenib could offer survival benefits to people with bowel (colorectal) cancer or gastrointestinal stromal tumour (GIST) following failure of existing treatments.

22 Nov 2012

Habitual physical activity improves midlife women's health

Moving 6,000 or more steps a day-no matter how-adds up to a healthier life for midlife women. That level of physical activity decreases the risk of diabetes and metabolic syndrome (a diabetes precursor and a risk for cardiovascular disease), showed a study published online this month in Menopause, the journal of the North American Menopause Society.

22 Nov 2012

Sleep deprivation could affect academic performance of college students

As fall semesters wind down at the country's colleges and universities, students will be pulling all-night study sessions to prepare for final exams. Ironically, the loss of sleep during these all-nighters could actually work against them performing well, says a Harris Health System sleep specialist.

22 Nov 2012

Five follow-up visits help gastric bypass patients achieve optimal weight loss

Gastric bypass patients who attended five follow-up office visits in two years as recommended by their surgeons lost nearly twice as much weight (113 lbs. vs. 57 lbs.) as patients who attended only two follow-up visits, according to a University of Pennsylvania School of Nursing study in Obesity Surgery.

22 Nov 2012

Regorafenib able to control resistant gastrointestinal stromal tumor

A new targeted drug demonstrated its ability to control metastatic gastrointestinal stromal tumor, an uncommon and life-threatening form of sarcoma, after the disease had become resistant to all existing therapies, report investigators at Dana-Farber Cancer Institute who led the worldwide clinical trial.

21 Nov 2012

HeartWare receives FDA approval for new left ventricular assist device

The U.S. Food and Drug Administration today approved the HeartWare Ventricular Assist System, a left ventricular assist device (LVAD), to support heart function and blood flow in patients with end-stage heart failure who are awaiting a heart transplant.

21 Nov 2012

Internet best method to communicate health messages to baby boomers

Communicating health information to the “baby boomer” generation might best be done via the internet, especially once they have hit 50, and then 65 years of age, suggest US researchers.

20 Nov 2012

Ventus Medical introduces Provent Sleep Apnea Therapy in Canada

Ventus Medical is pleased to announce the introduction of its proprietary Provent Sleep Apnea Therapy into Canada. Provent Therapy is an innovative, non-invasive treatment for obstructive sleep apnea (OSA).

20 Nov 2012

Positive results from Genentech Avastin plus temozolomide Phase III study on glioblastoma

Genentech, a member of the Roche Group, today announced results from the positive Phase III AVAglio study. The study showed Avastin (bevacizumab) in combination with radiation and temozolomide chemotherapy reduced the risk of cancer worsening or death (progression-free survival; PFS) by 36 percent compared to radiation and temozolomide chemotherapy plus placebo>th Annual Meeting of the Society for Neuro-Oncology in Washington, D.C.

19 Nov 2012